Jones Financial Companies
WST icon

Jones Financial Companies’s West Pharmaceutical WST Stock Holding History

Jones Financial Companies’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.39M Buy
26,246
+24,703
+1,601% +$6.15M ﹤0.01% 984
2025
Q4 		$424K Sell
1,543
-46
-3% -$12.6K ﹤0.01% 1591
2025
Q3 		$415K Sell
1,589
-5
-0.3% -$1.22K ﹤0.01% 1471
2025
Q2 		$349K Buy
1,594
+205
+15% +$43.8K ﹤0.01% 1426
2025
Q1 		$309K Buy
1,389
+278
+25% +$76.6K ﹤0.01% 1316
2024
Q4 		$364K Buy
1,111
+439
+65% +$138K ﹤0.01% 1117
2024
Q3 		$205K Buy
672
+660
+5,500% +$202K ﹤0.01% 1125
2024
Q2 		$3.96K Buy
12
+6
+100% +$2.12K ﹤0.01% 1994
2024
Q1 		$2.37K Hold
6
– – ﹤0.01% 1247
2023
Q4 		$2.11K Buy
+6
New +$2.12K ﹤0.01% 899
2021
Q2 		– Sell
-14
Closed -$4K – 795
2021
Q1 		$4K Buy
+14
New +$4.01K ﹤0.01% 684

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jones Financial Companies's WST Position: Q1 2026 in Review

Jones Financial Companies increased its West Pharmaceutical (WST) stake by 1,601% in Q1 2026, buying an estimated $6.15M and bringing the position to 26,246 shares worth $6.39M. The position accounts for ﹤0.01% of the portfolio, ranked #984.

Jones Financial Companies first reported a position in WST in Q1 2021 and has held it in 11 quarters since. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Jones Financial Companies held 26,246 shares of West Pharmaceutical worth $6.39M as of Q1 2026.
  • Jones Financial Companies bought 24,703 West Pharmaceutical shares in Q1 2026, an estimated $6.15M.
  • West Pharmaceutical made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #984 holding.
  • Jones Financial Companies first reported a position in West Pharmaceutical in Q1 2021 and has held it in 11 quarters since.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.